Disclosures for "Application of a Clinical-electrophysiologic Model for Distinguishing Chronic Inflammatory Demyelinating Neuropathy (CIDP) in an Australian Cohort"
-
Dr. Swart has nothing to disclose.
-
Dr. Garg has nothing to disclose.
-
Dr. Skolka has nothing to disclose.
-
Dr. Yiannikas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
-
Prof. Vucic has a non-compensated relationship as a Member-Advisory Board with Biogen Idec Australia that is relevant to AAN interests or activities. Prof. Vucic has a non-compensated relationship as a Honorarium with Merkc Serono Ausralia that is relevant to AAN interests or activities.
-
Dr. Pollard has nothing to disclose.
-
Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam and Sanofi. Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL.
-
Dr. Spies has nothing to disclose.
-
The institution of Prof. Kiernan has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for British Medical Journal Publishers (UK).
-
Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
-
Dr. Park has a non-compensated relationship as a Board Member with Toxic Neuropathy Consortium, Peripheral Nerve Society that is relevant to AAN interests or activities.